140 related articles for article (PubMed ID: 4426258)
1. [MVA vaccination against smallpox: clinical tests with an attenuated live vaccinia virus strain (MVA) (author's transl)].
Stickl H; Hochstein-Mintzel V; Mayr A; Huber HC; Schäfer H; Holzner A
Dtsch Med Wochenschr; 1974 Nov; 99(47):2386-92. PubMed ID: 4426258
[No Abstract] [Full Text] [Related]
2. Rapid protection in a monkeypox model by a single injection of a replication-deficient vaccinia virus.
Earl PL; Americo JL; Wyatt LS; Espenshade O; Bassler J; Gong K; Lin S; Peters E; Rhodes L; Spano YE; Silvera PM; Moss B
Proc Natl Acad Sci U S A; 2008 Aug; 105(31):10889-94. PubMed ID: 18678911
[TBL] [Abstract][Full Text] [Related]
3. Human Antibody Responses Following Vaccinia Immunization Using Protein Microarrays and Correlation With Cell-Mediated Immunity and Antibody-Dependent Cellular Cytotoxicity Responses.
Frey SE; Stapleton JT; Ballas ZK; Rasmussen WL; Kaufman TM; Blevins TP; Jensen TL; Davies DH; Tary-Lehmann M; Chaplin P; Hill H; Goll JB;
J Infect Dis; 2021 Oct; 224(8):1372-1382. PubMed ID: 33675226
[TBL] [Abstract][Full Text] [Related]
4. The Future of Smallpox Vaccination: is MVA the key?
Slifka MK
Med Immunol; 2005 Mar; 4(1):2. PubMed ID: 15740619
[TBL] [Abstract][Full Text] [Related]
5. Transgene expression knock-down in recombinant Modified Vaccinia virus Ankara vectors improves genetic stability and sustained transgene maintenance across multiple passages.
Neckermann P; Mohr M; Billmeier M; Karlas A; Boilesen DR; Thirion C; Holst PJ; Jordan I; Sandig V; Asbach B; Wagner R
Front Immunol; 2024; 15():1338492. PubMed ID: 38380318
[TBL] [Abstract][Full Text] [Related]
6. Time- and cost-effective production of untagged recombinant MVA by flow virometry and direct virus sorting.
Boselli D; Panigada M; Di Terlizzi S; Romanò M; Canonico E; Villa C; Minici C; van Anken E; Soprana E; Siccardi AG
J Transl Med; 2023 Jul; 21(1):495. PubMed ID: 37482614
[TBL] [Abstract][Full Text] [Related]
7. Immunogenicity and protective activity of mRNA vaccine candidates against yellow fever virus in animal models.
Medina-Magües LG; Mühe J; Jasny E; Medina-Magües ES; Roth N; Lopera-Madrid J; Salas-Quinchucua C; Knuese C; Petsch B; Osorio JE
NPJ Vaccines; 2023 Mar; 8(1):31. PubMed ID: 36871059
[TBL] [Abstract][Full Text] [Related]
8. Recent Advances in Cancer Vaccines: Challenges, Achievements, and Futuristic Prospects.
Gupta M; Wahi A; Sharma P; Nagpal R; Raina N; Kaurav M; Bhattacharya J; Rodrigues Oliveira SM; Dolma KG; Paul AK; de Lourdes Pereira M; Wilairatana P; Rahmatullah M; Nissapatorn V
Vaccines (Basel); 2022 Nov; 10(12):. PubMed ID: 36560420
[TBL] [Abstract][Full Text] [Related]
9. Intranasal inoculation of an MVA-based vaccine induces IgA and protects the respiratory tract of hACE2 mice from SARS-CoV-2 infection.
Americo JL; Cotter CA; Earl PL; Liu R; Moss B
Proc Natl Acad Sci U S A; 2022 Jun; 119(24):e2202069119. PubMed ID: 35679343
[TBL] [Abstract][Full Text] [Related]
10. Comparison of Recombinant MVA Selection Methods Based on F13L, D4R and K1L Genes.
Antoshkina IV; Glazkova DV; Urusov FA; Bogoslovskaya EV; Shipulin GA
Viruses; 2022 Mar; 14(3):. PubMed ID: 35336935
[TBL] [Abstract][Full Text] [Related]
11. Vaccinia Virus: From Crude Smallpox Vaccines to Elaborate Viral Vector Vaccine Design.
Kaynarcalidan O; Moreno Mascaraque S; Drexler I
Biomedicines; 2021 Nov; 9(12):. PubMed ID: 34944596
[TBL] [Abstract][Full Text] [Related]
12. Modified Vaccinia Virus Ankara as a Viral Vector for Vaccine Candidates against Chikungunya Virus.
García-Arriaza J; Esteban M; López D
Biomedicines; 2021 Aug; 9(9):. PubMed ID: 34572308
[TBL] [Abstract][Full Text] [Related]
13. Epicutaneous immunization with modified vaccinia Ankara viral vectors generates superior T cell immunity against a respiratory viral challenge.
Pan Y; Liu L; Tian T; Zhao J; Park CO; Lofftus SY; Stingley CA; Yan Y; Mei S; Liu X; Kupper TS
NPJ Vaccines; 2021 Jan; 6(1):1. PubMed ID: 33398010
[TBL] [Abstract][Full Text] [Related]
14. Emerging viruses and current strategies for vaccine intervention.
Afrough B; Dowall S; Hewson R
Clin Exp Immunol; 2019 May; 196(2):157-166. PubMed ID: 30993690
[TBL] [Abstract][Full Text] [Related]
15.
Giotis ES; Montillet G; Pain B; Skinner MA
Genes (Basel); 2019 Mar; 10(3):. PubMed ID: 30897824
[TBL] [Abstract][Full Text] [Related]
16. High titer MVA and influenza A virus production using a hybrid fed-batch/perfusion strategy with an ATF system.
Vázquez-Ramírez D; Jordan I; Sandig V; Genzel Y; Reichl U
Appl Microbiol Biotechnol; 2019 Apr; 103(7):3025-3035. PubMed ID: 30796494
[TBL] [Abstract][Full Text] [Related]
17. The Virulence of Different Vaccinia Virus Strains Is Directly Proportional to Their Ability To Downmodulate Specific Cell-Mediated Immune Compartments
de Freitas LFD; Oliveira RP; Miranda MCG; Rocha RP; Barbosa-Stancioli EF; Faria AMC; da Fonseca FG
J Virol; 2019 Mar; 93(6):. PubMed ID: 30567985
[TBL] [Abstract][Full Text] [Related]
18. Tracking Modified Vaccinia Virus Ankara in the Chicken Embryo: In Vivo Tropism and Pathogenesis of Egg Infections.
Langenmayer MC; Lülf-Averhoff AT; Adam-Neumair S; Sutter G; Volz A
Viruses; 2018 Aug; 10(9):. PubMed ID: 30149505
[TBL] [Abstract][Full Text] [Related]
19. Immunogenicity and Protection After Vaccination With a Modified Vaccinia Virus Ankara-Vectored Yellow Fever Vaccine in the Hamster Model.
Julander JG; Testori M; Cheminay C; Volkmann A
Front Immunol; 2018; 9():1756. PubMed ID: 30116244
[TBL] [Abstract][Full Text] [Related]
20. Swinepox virus vector-based vaccines: attenuation and biosafety assessments following subcutaneous prick inoculation.
Yuan X; Lin H; Li B; He K; Fan H
Vet Res; 2018 Feb; 49(1):14. PubMed ID: 29415767
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
